Hospital Partnerships Nozin’s Nasal Sanitizer is already trusted by hundreds of hospitals and healthcare professionals, indicating strong regional penetration and a ready-made pathway for expanding collaboration with more healthcare facilities and bundled infection prevention programs.

MRSA/MSSA Focus The company emphasizes MRSA/MSSA risk mitigation programs, suggesting sales opportunities with infection prevention teams seeking nasal decolonization solutions to reduce colonization-related infections and staff burden.

Expanded Programs Past launches of NOVA and NOVASM programs show a capability to scale programs that integrate prophylactic nasal antisepsis into facility workflows, offering a cross-sell of program services, training, and implementation support.

Public Mentions Regular recognition by The Leapfrog Group and media outlets positions Nozin as a validated, reputable solution in infection prevention, which can be leveraged in outreach to risk-averse hospitals and procurement teams.

Growth Readiness With reported revenue in the mid single digits to lower double digits and an SMB to mid-market employee footprint, there is potential to tailor scalable deployment offerings, partner channel strategies, and value-based pricing for mid-sized healthcare systems seeking cost reductions and infection risk management.